First Report Customer Care 
All time: 4.6

Latest / Last 30 Days: 5.0

526 Reviews

Credit Rating - EYEBIOTECH LIMITED

ANALYSIS
Credit Risk Update: ACCOUNTS DUE FLAG: EYEBIOTECH LIMITED, INTERNATIONAL BUILDING 71 KINGSWAY, HOLBORN, LONDON, WC2B 6ST. The legal status is a Private Limited Company and the current status at the registry of companies is Active. The last filed accounts are dated 31 December 2022. The company was incorporated on 9 July 2021.

The accounts next due date is 30 September 2024. There are no mortgages.

The above was based on public record information as at 20 September 2024 and may not reflect the current status. Please access the current report to ascertain the current status and credit rating.
SUMMARY
Registered Number: 13503296
Date Incorporated: 9 July 2021
Date Latest Accounts: 31 December 2022
BUSINESS INFORMATION
Legal Form: Private Limited Company
Previous Names: None
Registered Number: 13503296
Annual Return: Unknown
Registered Office: INTERNATIONAL BUILDING 71 KINGSWAY, HOLBORN, LONDON, WC2B 6ST
SIC Code and Operations: 72110
SECURED CREDITORS
Number of Mortgages 0
Satisfied Mortgages 0
Part Satisfied Mortgages 0
Unsatisfied Mortgages 0
CREDIT RISK RATING
This is the credit risk assessment used by one of the top UK credit reference agencies.
Risk Score (1-100):

EYEBIOTECH LIMITED

Click Here

to view this information

Risk Assessment:
Credit Rating:



First Report Score: (0-10):

Financial Status Guide:
10  trafficlight Very Strong
9   Strong
8 Very Good
7 Good
6 Above Average
5 Average
4 Below Average
3 Poor
2 Weak
1 Very Weak
0 Critical
Report Created On 30 September 2024 Copyright © 2024 First Report Ltd


Recent Searches

Reg No. Reg Name Status
09825961 EYEBIZDA LIMITED Dissolved
09328619 EYEBLINK HOLDING LIMITED Active - Proposal to Strike off
SC442620 EYEBLINK LTD Active
14441413 EYEBLINKLTD LIMITED Active - Proposal to Strike off
10069710 EYEBMUSIC PUBLISHING AND RECORDINGS LTD Active - Proposal to Strike off

In using this service you agree to the Terms and Conditions

© 2024 First Report Ltd